Why the study?
Does inhibition of CaMKII or Ras-GTPase prevent diabetes-induced abnormal vascular reactivity in the renal artery of diabetic rats?
Does inhibition of CaMKII or Ras-GTPase prevent diabetes-induced abnormal vascular reactivity in the renal artery of diabetic rats?
Inhibition of signal transduction involving CaMKII and Ras-GTPase can prevent the development of diabetes-induced abnormal vascular reactivity in the renal artery in a rat model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for CaMKII/Ras-GTPase inhibition in diabetic renal vasculopathy; leaves open translation to humans.
This study examined the role of Ca2+/calmodulin-dependent protein kinase II (CaMKII) and Ras-GTPase in the development of abnormal reactivity to vasoactive agents in the renal artery of diabetic rats. The vasoconstrictor response induced by norepinephrine (NE), endothelin-1 (ET-1) or angiotensin II (Ang II) was significantly increased whereas vasodilator response to carbachol, histamine or sodium nitroprusside (SNP) was not altered in the renal artery segments of the streptozotocin (STZ)-diabetic rats. Chronic intraperitoneal administration of KN-93 (5 mg/kg/ alt diem), an inhibitor of CaMKII or FPTIII (1.5 mg/kg/ alt diem), an inhibitor of Ras-GTPase, produced significant normalization of the altered agonist-induced vasoconstrictor responses without affecting blood glucose levels. All the inhibitors were administered for four weeks starting from day one of diabetes induction. Inhibition of Ras-GTPase or CaMKII did not affect the agonist-induced vasoconstrictor and vasodilator responses in the non-diabetic control animals. These data suggest that inhibition of signal transduction involving CaMKII and Ras-GTPase can prevent development of diabetes-induced abnormal vascular reactivity in the renal artery.
No takes yet. Share an insight, caveat, or question.
Mariam H.M. Yousif (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: